The client’s voice: why they consistently choose Kayentis
At Kayentis, client satisfaction isn’t just a goal—it’s our standard. We pride ourselves on delivering
Rare Disease Case Study
Over 90% of rare diseases have no treatment…
Understanding the rare disease framework is key to be able to offer study participants adapted solutions and as such, positively contribute to important and necessary clinical research conducted on rare diseases.
Kayentis offers an extensive experience in rare disease clinical trials, in indications such as:
Learn more:
At Kayentis, client satisfaction isn’t just a goal—it’s our standard. We pride ourselves on delivering
At Kayentis, we value each individual and we form a community that goes beyond the
In this last episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Integrating PROs into studies on MASH, also known as NASH, is crucial. MASH is a debilitating
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of
Last update : 30 March 2023